We are thrilled to announce that Sastodeal, Nepal's leading e-commerce platform, has successfully secured funding amounting to NPR 200 million (approximately USD 1.6 million) in its latest financing round. This significant investment will propel our efforts to enhance the online shopping experience for our valued customers across Nepal. Established with the vision of transforming the e-commerce landscape in the country, Sastodeal has consistently championed local products, empowering small businesses to reach a wider audience while providing consumers with a diverse range of quality goods. The funds acquired will primarily be allocated towards expanding our logistics capabilities, ensuring faster delivery times, and improving our technological infrastructure to offer a seamless shopping experience. Additionally, this funding round will allow us to further invest in marketing strategies aimed at increasing awareness of our platform and promoting local Nepali products. With an ever-growing demand for online shopping, particularly in the wake of the global pandemic, we are committed to tapping into the immense potential of e-commerce in Nepal. We believe that this investment will not only help us consolidate our market leadership but also play a pivotal role in nurturing the local economy by supporting our partners and vendors throughout the region. We are excited about the road ahead and look forward to taking Sastodeal to new heights as we continue to serve our community with dedication and innovation. Thank you to our investors for believing in our vision and joining us on this journey!
Breaking News: Sastodeal Secures Major Funding to Propel Nepal's Ecommerce Growth
Get the full Sastodeal company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Beeline Medicines
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. We are here to chart a new path for patients, rigorously pushing the science forward to deliver therapies that go straight to the drivers of immune dysfunction to define new treatment paradigms. Our portfolio is comprised of therapeutic candidates rooted in validated biology, powered by best-in-class molecular properties, and driven by an efficient clinical development strategy designed for differentiated, lasting impact for patients. Grounded in scientific rigor and driven by purpose, we get to what matters so that people living with immune-mediated diseases can live life fully.
$126.3M Series a
today
Revoraai
Most real estate businesses don’t have a lead problem. They have a conversion problem. Leads come in… But slow replies, missed follow-ups, and unqualified inquiries kill deals. That’s where I help. I build AI-powered systems that: • Instantly respond to new leads • Filter serious buyers • Follow up automatically • Turn conversations into site visits No manual chasing. No missed opportunities. Just a smarter way to convert leads into revenue. If you're in real estate and want to automate your lead flow, let’s connect.
$2.0M Seed
today
LEKO
LEKO Labs is accelerating the global transition to carbon negative construction with building materials powered by AI optimization and robotic manufacturing.
$9.0M Seed
today
Wolf-e Robotics
EU Manufacturer of Smart #UVC Disinfection Devices. Air Purifiers, Applied UV Robotics, Research & Development Platform. Gausium cleaning robots distributor. Democratizing clean air and surfaces in any indoor space. For collabs & enquiries, check our website: www.wolfe.ro.
$54.0K Unknown
today
OxidOS Automotive
OxidOS Automotive is building the next generation of software development tools and Operating Systems for Automotive ECUs, fully written in Rust. The OxidOS platform and Operating System allow automotive manufacturers and integrators to deploy safe and secure software faster, through development, debugging, and certification time reduction.
$54.0K Unknown
today